相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma
Zenghui Gu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
H19X-encoded miR-424(322)/-503 cluster: emerging roles in cell differentiation, proliferation, plasticity and metabolism
Fan Wang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5
Jingbang Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Modeling qRT-PCR dynamics with application to cancer biomarker quantification
Inna Chervoneva et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition
Zhiyu Ye et al.
ONCOLOGY LETTERS (2018)
Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer
Jingjing Liu et al.
CELL CYCLE (2018)
MicroRNA Key to Angiogenesis Regulation: miRNA Biology and Therapy
Ankit Tiwari et al.
CURRENT CANCER DRUG TARGETS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Marcel Klingenberg et al.
JOURNAL OF HEPATOLOGY (2017)
Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression
Jing Zhang et al.
MOLECULAR CANCER (2017)
The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer
Ashok Shiani et al.
CANCER CONTROL (2017)
ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition
Tao Xu et al.
CANCER LETTERS (2016)
LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway
Shi-Peng Li et al.
ONCOTARGET (2016)
Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195
Hui Zhang et al.
MEDICAL SCIENCE MONITOR (2016)
Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling
Wei-Ming Fu et al.
JOURNAL OF HEPATOLOGY (2015)
Treatment of Liver Cancer
Chun-Yu Liu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Five-year Relative Survival Rate of Liver Cancer in the USA, Europe and Japan
Kota Katanoda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression
Ying Zhang et al.
SCIENTIFIC REPORTS (2014)
The Design of a Quantitative Western Blot Experiment
Sean C. Taylor et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer
J. Xu et al.
ONCOGENE (2013)
Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma
Jing Cui et al.
TUMOR BIOLOGY (2013)
Epithelial-mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
Chiara Foroni et al.
CANCER TREATMENT REVIEWS (2012)
ARK5 is associated with the invasive and metastatic potential of human breast cancer cells
Xin-Zhong Chang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena et al.
CELL (2011)
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
Angeliki Voulgari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
Shu-Chun Chuang et al.
CANCER LETTERS (2009)
分享论文
